Duodenal switch: an effective therapy for morbid obesity--intermediate results

Obes Surg. 2001 Feb;11(1):54-8. doi: 10.1381/096089201321454114.

Abstract

Background: The duodenal switch (DS) is a variant of the biliopancreatic diversion (BPD), with a vertical subtotal gastrectomy and pylorus preservation.

Methods: DS was used to treat morbid obesity in 125 patients, with mean BMI 50, with 65% of the patients super obese (SO). Patients have been followed for an intermediate period.

Results: The percentage of excess weight loss (%EWL) was > 70% at 1 year, and reached 81.4% at 5 years when 97% of the patients had a %EWL > 50%. Comorbidities were cured or improved in all patients.

Conclusion: DS was very effective for the treatment of the morbid obesity in the SO patients.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Biliopancreatic Diversion / adverse effects*
  • Biliopancreatic Diversion / methods*
  • Biliopancreatic Diversion / mortality
  • Body Mass Index
  • Esophagitis, Peptic / etiology
  • Esophagitis, Peptic / prevention & control
  • Female
  • Follow-Up Studies
  • Gastrectomy / adverse effects*
  • Gastrectomy / methods*
  • Gastrectomy / mortality
  • Humans
  • Length of Stay / statistics & numerical data
  • Male
  • Middle Aged
  • Obesity, Morbid / classification
  • Obesity, Morbid / diagnosis
  • Obesity, Morbid / surgery*
  • Postgastrectomy Syndromes / etiology
  • Postgastrectomy Syndromes / prevention & control
  • Protein-Energy Malnutrition / etiology
  • Reoperation
  • Severity of Illness Index
  • Suture Techniques
  • Treatment Outcome
  • Weight Loss